(Q37602644)

21 August 2017

Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy (English)

1 reference

juvenile rheumatoid arthritis

21 August 2017

0 references

1 reference

Kristin Houghton

14

0 references

Pierre Quartier

object named as

Pierre Quartier

5

0 references

Nicolino Ruperto

26

object named as

Nicolino Ruperto

1 reference

21 August 2017

3

Nico Wulffraat

1 reference

21 August 2017

9

Lidia Rutkowska-Sak

1 reference

21 August 2017

Arndt H Brachat

1

1 reference

21 August 2017

Alexei A Grom

2

1 reference

21 August 2017

Hermine I Brunner

4

1 reference

21 August 2017

Riva Brik

6

1 reference

21 August 2017

Liza McCann

7

1 reference

21 August 2017

Huri Ozdogan

8

1 reference

21 August 2017

Rayfel Schneider

10

1 reference

21 August 2017

Valeria Gerloni

11

1 reference

21 August 2017

Liora Harel

12

1 reference

21 August 2017

Maria Terreri

13

1 reference

21 August 2017

Rik Joos

15

1 reference

21 August 2017

Daniel Kingsbury

16

1 reference

21 August 2017

Jorge M Lopez-Benitez

17

1 reference

21 August 2017

Stephan Bek

18

1 reference

21 August 2017

Martin Schumacher

19

1 reference

21 August 2017

Marie-Anne Valentin

20

1 reference

21 August 2017

Hermann Gram

21

1 reference

21 August 2017

Ken Abrams

22

1 reference

21 August 2017

Alberto Martini

23

1 reference

21 August 2017

Daniel J Lovell

24

1 reference

21 August 2017

Nanguneri R Nirmala

25

1 reference

21 August 2017

Pediatric Rheumatology International Trials Organization (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG)

27

1 reference

21 August 2017

23 January 2017

1 reference

Arthritis Research and Therapy

21 August 2017

1 reference

21 August 2017

19

1 reference

21 August 2017

1

1 reference

21 August 2017

13

1 reference

https://scigraph.springernature.com/pub.10.1186/s13075-016-1212-x

21 August 2017

0 references

cites work

Gene-expression analysis of adult-onset Still's disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

Use of canakinumab in the cryopyrin-associated periodic syndrome

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

Summaries of Affymetrix GeneChip probe level data

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

It is time to rethink juvenile idiopathic arthritis classification and nomenclature.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5260050

Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data

1 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FS13075-016-1212-X

Juvenile idiopathic arthritis

21 January 2018

1 reference

12 December 2020

Juvenile idiopathic arthritis

1 reference

12 December 2020

Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ

1 reference

12 December 2020

Specific gene expression profiles in systemic juvenile idiopathic arthritis

1 reference

12 December 2020

Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis

1 reference

12 December 2020

Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis

1 reference

12 December 2020

10.1186/S13075-016-1212-X

Identifiers

DOI

1 reference

Dimensions Publication ID

21 August 2017

0 references

1 reference

21 August 2017

PubMed publication ID

28115015

1 reference